Ester Mejstříková

6.3k total citations
68 papers, 1.4k citations indexed

About

Ester Mejstříková is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Ester Mejstříková has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 34 papers in Public Health, Environmental and Occupational Health and 18 papers in Molecular Biology. Recurrent topics in Ester Mejstříková's work include Acute Lymphoblastic Leukemia research (34 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Ester Mejstříková is often cited by papers focused on Acute Lymphoblastic Leukemia research (34 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Ester Mejstříková collaborates with scholars based in Czechia, Germany and Netherlands. Ester Mejstříková's co-authors include Ondřej Hrušák, Jan Trka, Jan Starý, Eva Froňková, Tomáš Kalina, Michael Dworzak, Jacques J. M. van Dongen, Petr Sedláček, Júlia Starková and Renata Formánková and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ester Mejstříková

65 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ester Mejstříková

Since Specialization

Citations

This map shows the geographic impact of Ester Mejstříková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Mejstříková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Mejstříková more than expected).

Fields of papers citing papers by Ester Mejstříková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Mejstříková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Mejstříková. The network helps show where Ester Mejstříková may publish in the future.

Co-authorship network of co-authors of Ester Mejstříková

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Mejstříková. A scholar is included among the top collaborators of Ester Mejstříková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Mejstříková. Ester Mejstříková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD38: A target in relapsed/refractory acute lymphoblastic leukemia—Limitations in treatment and diagnostics 2022 ·Pediatric Blood & Cancer ·(unknown), Michaela Nováková, (unknown), Markéta Žaliová, Eva Froňková, Ester Mejstříková, Jan Starý, Ondřej Hrušák, Lucie Šrámková	4
2	<i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch 2020 ·Haematologica ·Michaela Nováková, Markéta Žaliová, Karel Fišer, (unknown), (unknown), Alena Musilová, Monika Brüggemann, Matthias Ritgen, Eva Froňková, Tomáš Kalina, Jan Starý, (unknown), Peter Švec, Alexandra Kolenová, Jan Stuchlý, Jan Zuna, Jan Trka, Ondřej Hrušák, Ester Mejstříková	32
3	EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System 2019 ·Frontiers in Immunology ·Jacques J. M. van Dongen, Mirjam van der Burg, Tomáš Kalina, Martín Pérez‐Andrés, Ester Mejstříková, Marcela Vlková, Eduardo López‐Granados, Marjolein Wentink, Anne‐Kathrin Kienzler, Jan Philippé, Ana E. Sousa, Menno C. van Zelm, Elena Blanco, Alberto Órfão	38
4	ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity 2019 ·Haematologica ·Markéta Žaliová, Eliška Potůčková, (unknown), Alena Musilová, (unknown), Karel Fišer, Jan Stuchlý, Ester Mejstříková, Júlia Starková, Jan Zuna, Jan Starý, Jan Trka	31
5	Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 2018 ·Journal of Immunological Methods ·Łukasz Sędek, Prisca Theunissen, Elaine Sobral da Costa, (unknown), Ester Mejstříková, Giuseppe Gaipa, (unknown), (unknown), Elen Oliveira, Michaela Nováková, Chiara Buracchi, Jacques J. M. van Dongen, Alberto Órfão, Vincent H. J. van der Velden, Tomasz Szczepański	42
6	Detailed immunophenotyping of B‐cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection 2017 ·British Journal of Haematology ·Prisca Theunissen, Łukasz Sędek, Válerie de Haas, Tomasz Szczepański, (unknown), Ester Mejstříková, Michaela Nováková, Tomáš Kalina, Quentin Lécrevisse, Alberto Órfão, Arjan C. Lankester, Jacques J. M. van Dongen, Vincent H. J. van der Velden	25
7	Low marginal zone-like B lymphocytes and natural antibodies characterize skewed B-lymphocyte subpopulations in del22q11 DiGeorge patients 2015 ·Clinical Immunology ·Adam Klocperk, Ester Mejstříková, Jana Kayserová, Tomáš Kalina, Anna Šedivá	10
8	Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency 2015 ·Journal of Allergy and Clinical Immunology ·Kerstin Felgentreff, Yu Nee Lee, Francesco Frugoni, Likun Du, Mirjam van der Burg, Silvia Giliani, İlhan Tezcan, İsmail Reisli, Ester Mejstříková, Jean‐Pierre de Villartay, Barry P. Sleckman, John Manis, Luigi D. Notarangelo	48
9	Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia 2015 ·Haematologica ·Leonid Karawajew, Michael Dworzak, Richard Ratei, Peter Rhein, Giuseppe Gaipa, Barbara Buldini, Giuseppe Basso, Ondřej Hrušák, Wolfgang Ludwig, G. Henze, K. Seeger, Arend von Stackelberg, Ester Mejstříková, Cornelia Eckert	47
10	Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients 2014 ·European Cytokine Network ·(unknown), Martina Vašková, (unknown), (unknown), Ester Mejstříková, Tomáš Kalina, Markéta Žaliová, Jaroslav Weiser, Jan Starý, Ondřej Hrušák	4
11	Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5) 2012 ·Blood ·Julia Pagel, Karin Beutel, Kai Lehmberg, (unknown), Andrea Maul‐Pavicic, (unknown), Abdullah Al‐Jefri, Rita Beier, Lilian Bomme Ousager, Karoline Ehlert, U. Gross‐Wieltsch, Norbert Jorch, Bernhard Kremens, Arnulf Pekrun, Monika Sparber‐Sauer, Ester Mejstříková, Angela Wawer, Stephan Ehl, Udo zur Stadt, Gritta Janka	118
12	Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically 2012 ·Cancer Letters ·Michal Zápotocký, Ester Mejstříková, Karel Smetana, Jan Starý, Jan Trka, Júlia Starková	25
13	Uncommon leukemic case of anaplastic large cell lymphoma diagnosed through a typical chromosomal abnormality t(2;5) with a null phenotype and aberrant expression of NG2 and CD13 2012 ·Bratislavské lekárske listy/Bratislava medical journal ·Alexandra Kolenová, Ester Mejstříková, (unknown), (unknown), Lukáš Plank, P Szépe, (unknown), (unknown), (unknown), E Kaiserová	1
14	Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria 2010 ·Haematologica ·Ester Mejstříková, (unknown), Eva Froňková, (unknown), Tomáš Kalina, Jaroslav Štěrba, Y. Jabali, Vladimír Mihál, (unknown), (unknown), Dagmar Procházková, Jiří Hák, Zuzana Zemanová, Marie Jarošová, Alexandra Oltová, Petr Sedláček, (unknown), Jan Zuna, Jan Trka, Jan Starý, Ondřej Hrušák	42
15	HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL 2010 ·Pediatric Blood & Cancer ·Júlia Starková, (unknown), Ester Mejstříková, Roman Krejčí, Harry A. Drabkin, Jan Trka	24
16	Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring 2009 ·Leukemia ·Markéta Žaliová, Eva Froňková, Kateřina Krejčíková, (unknown), Ester Mejstříková, Jan Starý, Jan Trka, Jan Zuna	26
17	B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL 2008 ·Bone Marrow Transplantation ·Eva Froňková, (unknown), Ester Mejstříková, (unknown), Renata Formánková, Petr Sedláček, Ondřej Hrušák, Jan Starý, Jan Trka	46
18	Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen‐mismatched unrelated donors 2007 ·Pediatric Transplantation ·Petr Sedláček, Renata Formánková, Ester Mejstříková, Petra Keslová, Petr Hubáček, Marie Dobrovolná, (unknown), (unknown), (unknown), Jan Starý	4
19	Childhood secondary ALL after ALL treatment 2007 ·Leukemia ·Jan Zuna, Hélène Cavé, Cornelia Eckert, Tomasz Szczepański, Claus Meyer, Ester Mejstříková, Eva Froňková, (unknown), Emmanuelle Clappier, (unknown), Patrick Boutard, André Schrauder, Jaroslav Štěrba, Rolf Marschalek, Jacques J. M. van Dongen, Ondřej Hrušák, Jan Starý, Jan Trka	18
20	Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia 2006 ·Pediatric Blood & Cancer ·Lucie Šrámková, Kateřina Mužíková, Eva Froňková, Ondřej Krejčí, Petr Sedláček, Renata Formánková, Ester Mejstříková, Jan Starý, Jan Trka	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact